United Therapeutics Corp. (UTHR)
598.64
+5.10
(+0.86%)
USD |
NASDAQ |
Oct 30, 11:13
United Therapeutics Cash and Short Term Investments (Annual) : 2.920B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.920B |
| December 31, 2024 | 3.267B |
| December 31, 2023 | 2.994B |
| December 31, 2022 | 2.839B |
| December 31, 2021 | 1.931B |
| December 31, 2020 | 1.835B |
| December 31, 2019 | 1.486B |
| December 31, 2018 | 1.416B |
| December 31, 2017 | 927.40M |
| December 31, 2016 | 1.051B |
| December 31, 2015 | 953.77M |
| December 31, 2014 | 695.54M |
| December 31, 2013 | 688.53M |
| December 31, 2012 | 479.20M |
| Date | Value |
|---|---|
| December 31, 2011 | 403.48M |
| December 31, 2010 | 627.08M |
| December 31, 2009 | 229.49M |
| December 31, 2008 | 236.05M |
| December 31, 2007 | 290.05M |
| December 31, 2006 | 227.75M |
| December 31, 2005 | 125.48M |
| December 31, 2004 | 82.79M |
| December 31, 2003 | 68.56M |
| December 31, 2002 | 122.66M |
| December 31, 2001 | 56.05M |
| December 31, 2000 | 215.42M |
| December 31, 1999 | 51.60M |
| December 31, 1998 | 16.80M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Liquidia Corp. | 190.68M |
| MannKind Corp. | 171.35M |
| Gilead Sciences, Inc. | 9.613B |
| Insmed, Inc. | 1.430B |
| Alnylam Pharmaceuticals, Inc. | 2.908B |